| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c902faf6ae746c51fc8010672fc22894 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-541
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 |
| filingDate |
1999-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2004-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43140a18a58c680a5370a4e8bf7914bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70c71b1bb7d463d288433b68a1ed02fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd69358294cf51d01d9f0540300fdd47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7924f1dbf75753f891790dfc3997d30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6dc27609b8b6bf38db812a871c71b32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_708b85c801787a0cc5ea255b3715ef3f |
| publicationDate |
2004-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1140851-B1 |
| titleOfInvention |
4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents |
| abstract |
The present invention provides a compound of formula IWherein R1 is C1-7 alkyl, optionally substituted by hydroxy or NR4R5; R2 is C1-7 alkyl substituted by hydroxy or NR4R5; R3 is H, F or C1-7 alkoxy; R4 and R5 together with N are a 5- or 6-membered heterocyclic moiety having 1-3 heteroatoms selected from the group consisting of nitrogen, oxygen and sulfur in which sulfur may be substituted by one (1) or two (2) oxygen atoms; and pharmaceutically acceptable salts thereof Compounds of formula I of the present invention are useful as antiviral agents. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8232401-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7635704-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7176220-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8981103-B2 |
| priorityDate |
1999-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |